Literature DB >> 33403985

COVID deaths in South Africa: 99 days since South Africa's first death.

V Pillay-van Wyk1, D Bradshaw, P Groenewald, I Seocharan, S Manda, R A Roomaney, O Awotiwon, T Nkwenika, G Gray, S S Buthelezi, Z L Mkhize.   

Abstract

BACKGROUND: Understanding the pattern of deaths from COVID-19 in South Africa (SA) is critical to identifying individuals at high risk of dying from the disease. The Minister of Health set up a daily reporting mechanism to obtain timeous details of COVID-19 deaths from the provinces to track mortality patterns.
OBJECTIVES: To provide an epidemiological analysis of the first COVID-19 deaths in SA.
METHODS: Provincial deaths data from 28 March to 3 July 2020 were cleaned, information on comorbidities was standardised, and data were aggregated into a single data set. Analysis was performed by age, sex, province, date of death and comorbidities.
RESULTS: SA reported 3 088 deaths from COVID-19, i.e. an age-standardised death rate of 64.5 (95% confidence interval (CI) 62.3 - 66.8) deaths per million population. Most deaths occurred in Western Cape (65.5%) followed by Eastern Cape (16.8%) and Gauteng (11.3%). The median age of death was 61 years (interquartile range 52 - 71). Males had a 1.5 times higher death rate compared with females. Individuals with two or more comorbidities accounted for 58.6% (95% CI 56.6 - 60.5) of deaths. Hypertension and diabetes were the most common comorbidities reported, and HIV and tuberculosis were more common in individuals aged <50 years.
CONCLUSIONS: Data collection for COVID-19 deaths in provinces must be standardised. Even though the data had limitations, these findings can be used by the SA government to manage the pandemic and identify individuals who are at high risk of dying from COVID-19.

Entities:  

Year:  2020        PMID: 33403985

Source DB:  PubMed          Journal:  S Afr Med J


  7 in total

1.  Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19.

Authors:  Jacqui Venturas; Jarrod Zamparini; Erica Shaddock; Sarah Stacey; Lyle Murray; Guy A Richards; Ismail Kalla; Adam Mahomed; Farzahna Mohamed; Mervyn Mer; Innocent Maposa; Charles Feldman
Journal:  J Infect       Date:  2021-05-26       Impact factor: 38.637

2.  Time to death and risk factors associated with mortality among COVID-19 cases in countries within the WHO African region in the early stages of the COVID-19 pandemic.

Authors:  Benido Impouma; Alice L J Carr; Alexander Spina; Franck Mboussou; Opeayo Ogundiran; Fleury Moussana; George Sie Williams; Caitlin M Wolfe; Bridget Farham; Antoine Flahault; Claudia Codeco Tores; Jessica L Abbate; Flávio Codeço Coelho; Olivia Keiser
Journal:  Epidemiol Infect       Date:  2022-02-18       Impact factor: 2.451

3.  COVID-19 hospitalization and mortality and hospitalization-related utilization and expenditure: Analysis of a South African private health insured population.

Authors:  Geetesh Solanki; Thomas Wilkinson; Shailav Bansal; Joshila Shiba; Samuel Manda; Tanya Doherty
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.752

4.  COVID-19 onset reduced the sex ratio at birth in South Africa.

Authors:  Gwinyai Masukume; Margaret Ryan; Rumbidzai Masukume; Dorota Zammit; Victor Grech; Witness Mapanga
Journal:  PeerJ       Date:  2022-08-29       Impact factor: 3.061

Review 5.  Cochleovestibular findings linked to COVID-19: A scoping review for clinical care planning in South Africa.

Authors:  Katijah Khoza-Shangase
Journal:  S Afr J Commun Disord       Date:  2022-08-12

Review 6.  Clinical Outcomes of Individuals with COVID-19 and Tuberculosis during the Pre-Vaccination Period of the Pandemic: A Systematic Review.

Authors:  Tulip A Jhaveri; Celia Fung; Allison N LaHood; Andrew Lindeborg; Chengbo Zeng; Rifat Rahman; Paul A Bain; Gustavo E Velásquez; Carole D Mitnick
Journal:  J Clin Med       Date:  2022-09-26       Impact factor: 4.964

Review 7.  A Pandemic within Other Pandemics. When a Multiple Infection of a Host Occurs: SARS-CoV-2, HIV and Mycobacterium tuberculosis.

Authors:  Carmen María González-Domenech; Isabel Pérez-Hernández; Cristina Gómez-Ayerbe; Isabel Viciana Ramos; Rosario Palacios-Muñoz; Jesús Santos
Journal:  Viruses       Date:  2021-05-17       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.